Pomerantz Law Firm Launches Investigation into Inovio Pharmaceuticals for Potential Investor Misconduct Pomerantz Law Firm is investigating Inovio Pharmaceuticals over potential securities fraud after FDA findings impacted investor interests.

Pomerantz Law Firm Launches Investigation into Inovio Pharmaceuticals for Potential Investor Misconduct #USA #New_York #Pomerantz_LLP #INOVIO_Pharmaceuticals #SEC_Claims

Faruqi & Faruqi Investigates Claims for SelectQuote Investors Amid Legal Concerns Faruqi & Faruqi, LLP is actively investigating claims regarding SelectQuote to help investors recover losses due to alleged misconduct involving Medicare plans.

Faruqi & Faruqi Investigates Claims for SelectQuote Investors Amid Legal Concerns #USA #New_York #Faruqi_&_Faruqi #SEC_Claims #SelectQuote

Faruqi & Faruqi Investigates Potential Securities Claims for Unicycive Investors Faruqi & Faruqi, LLP is encouraging Unicycive investors who incurred losses to reach out regarding their legal options and to discuss potential claims against the company.

Faruqi & Faruqi Investigates Potential Securities Claims for Unicycive Investors #USA #New_York #Faruqi_&_Faruqi #SEC_Claims #Unicycive

Pomerantz Law Firm Launches Investigation into Capricor Therapeutics for Potential Securities Fraud Pomerantz LLP is examining potential claims against Capricor Therapeutics, Inc., following a significant stock drop post-FDA review announcement.

Pomerantz Law Firm Launches Investigation into Capricor Therapeutics for Potential Securities Fraud #United_States #New_York #Pomerantz_LLP #SEC_Claims #Capricor_Therapeutics

Investors Urged to Act as Faruqi & Faruqi Investigates Sana Biotechnology Claims Faruqi & Faruqi, a national securities law firm, is examining claims against Sana Biotechnology. Investors affected by losses may take action before the deadline.

Investors Urged to Act as Faruqi & Faruqi Investigates Sana Biotechnology Claims #USA #New_York #Sana_Biotechnology #Faruqi_&_Faruqi #SEC_Claims

SEC Announces Distribution Payment Claims for Comscore Investors Following Fraud Settlement Comscore investors who purchased shares from 2014 to 2018 can file claims for losses after a $5.7M settlement for fraudulent practices.

SEC Announces Distribution Payment Claims for Comscore Investors Following Fraud Settlement #Seattle #Comscore_Fair_Fund #SEC_Claims #Matta_Settlement